Jones Day has advised BioMarin Pharmaceutical Inc. in the acquisition of Amicus Therapeutics. Kirkland & Ellis has advised Amicus Therapeutics. BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has...
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion
Aypa Power’s Closing of $650 Million Senior Secured Multi-Tranche Hybrid Credit Facility
Kirkland & Ellis advised Aypa Power I LLC on the deal, and Norton Rose Fulbright advised the lenders. Aypa Power I LLC, a portfolio company of...


























